SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-063829
Filing Date
2021-05-10
Accepted
2021-05-10 16:04:27
Documents
4
Group Members
D. E. SHAW & CO., L.L.C.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2115545d1_sc13g.htm SC 13G 57728
2 EXHIBIT 1 tm2115545d1_ex1.htm EX-99.1 5801
3 EXHIBIT 2 tm2115545d1_ex2.htm EX-99.2 5984
4 EXHIBIT 3 tm2115545d1_ex3.htm EX-99.3 5185
  Complete submission text file 0001104659-21-063829.txt   76657
Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

IRS No.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88625 | Film No.: 21907036
SIC: 8071 Services-Medical Laboratories